Evaluating inflammatory biomarkers as predictors of outcomes and immune-related adverse events (irAE) in the Big Ten Cancer Research Consortium (BTCRC) LUN16-081 phase II clinical trial.
Authors: Greg Andrew Durm, Sandra K. Althouse, Hirva Mamdani, Tushar Sardesai, Shadia Ibrahim Jalal, Nasser H. Hanna